Similarly, the decrease in Igf-1 and Irs-1 mRNA expression observed in SI-treated samples suggests its potential to enhance insulin sensitivity and regulate ovarian function; this reduction in expression levels could help alleviate symptoms associated with PCOS, such as insulin resistance and hormone imbalance, offering a promising therapeutic intervention for PCOS. This evidence concerns the gene IGF1 and polycystic ovary syndrome.